Dalbavancin Therapy for Infective Endocarditis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study compares two treatment strategies for antibiotic therapy in endocarditis. The aim of the study is to determine which treatment is more effective overall and better tolerated by patients. The first strategy is standard therapy: treatment with proven antibiotics, which are usually administered initially as an intravenous infusion in the hospital and can be switched to oral therapy with tablets later on for suitable patients. The second strategy is the study treatment with dalbavancin: This is a long-acting antibiotic. It is administered as a single infusion; for longer treatment durations, a second infusion may be necessary 14 days later.
Epistemonikos ID: b821ffd1f3a989f719e1112fe8d824d1fff6d370
First added on: Jul 14, 2026